Domundi SAS

Domundi SAS discloses dealings in Abionyx Pharma to AMF. The record holds 4 filings, for trades running from 23 May 2023 to 22 June 2026.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Most recently, on 24 June 2026, the filings show a transaction worth €100k in Abionyx Pharma. The median gap between a trade and its publication by AMF is 2 days. For comparison, MAR article 19 gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by AMF. They describe what insiders did and are not a recommendation.